Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Clin Cancer Res. 2008 Nov 1;14(21):6847–6854. doi: 10.1158/1078-0432.CCR-08-1387

Table 1.

Frequency of MSI-H phenotype in unselected ovarian cancers

Reference Study location No. markers Sample size No. MSI-H
Allen et al., 2000 (21) Buffalo, NY 4 26 1 (4%)
Alvi et al., 2001 (22) St. Louis, MO 5 43 3 (7%)
Buller et al., 2001 (23) Iowa City, IA 6 116 24 (20%)
Codegoni et al., 1999 (24) Milan, Italy 8 31 8 (26%)
Dellas et al., 2004 (25) Basel, Switzerland 5 66 20 (30%)
Fujita et al., 1995 (36) Osaka, Japan 4 47 8 (17%)
Geisler et al., 2003 (10) Iowa City, IA 6 107 21 (20%)
Gras et al., 2001 (11) Barcelona, Spain 5 42 2 (5%)
Han et al., 1993 (27) Seoul, Korea 4 19 1 (5%)
Iwabuchi et al., 1995 (28) New Haven, CT 66 95 6 (6%)
King et al., 1995 (29) New Haven, CT and Friedburg, Germany 2 41 7 (17%)
Kobayashi et al., 1995 (30) Hokkaido, Japan 5 68 2 (3%)
Krajinovic et al., 1998 (31) Montreal, Canada 8 12 2 (17%)
Osborne et al., 1994 (32) Cambridge, United Kingdom 9 25 2 (8%)
Shih et al., 1998 (33) Queensland, Australia 69 31 0 (0%)
Sood et al., 1996 (34) Iowa City, IA 10 68 25 (37%)
Sood et al., 2001 (35) Iowa City, IA 14 109 13 (12%)
Tangir et al., 1996 (36) Boston, MA 13 31 0 (0%)
HHS Vulnerability Disclosure